{"entity":{"type":"insider","cik":"0001300997","url":"/insider/0001300997","json_url":"/insider/0001300997.json","name":"Wotton Paul K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":21,"first":"2008-11-19","last":"2026-05-13","span_basis":"filed_date"},"name_variants":[{"name":"Wotton Paul K","source":"filing","n_filings":21,"first_seen":"2008-11-19","last_seen":"2026-05-13"}],"transactions":[{"id":6110260,"accession":"0001140361-26-021040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-26-021040","line_url":"/filing/0001140361-26-021040","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.7425,"price_display":"32.74","price_state":"stated","total_value":327425.0,"total_display":"327,425.00","total_whole":"327,425","shares_owned_after":18802.0,"shares_owned_after_display":"18,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider","n_lines":2},{"id":4844576,"accession":"0001140361-25-044347","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-25-044347","line_url":"/filing/0001140361-25-044347#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":37.83,"price_display":"37.83","price_state":"stated","total_value":94575.0,"total_display":"94,575.00","total_whole":"94,575","shares_owned_after":25602.0,"shares_owned_after_display":"25,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4844572,"accession":"0001140361-25-044347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-25-044347","line_url":"/filing/0001140361-25-044347#line-1","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":37.97,"price_display":"37.97","price_state":"stated","total_value":94925.0,"total_display":"94,925.00","total_whole":"94,925","shares_owned_after":28102.0,"shares_owned_after_display":"28,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":3242734,"accession":"0001140361-24-048466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-24-048466","line_url":"/filing/0001140361-24-048466#line-1","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":58.72,"price_display":"58.72","price_state":"stated","total_value":152672.0,"total_display":"152,672.00","total_whole":"152,672","shares_owned_after":27402.0,"shares_owned_after_display":"27,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-05","scope":"insider"},{"id":8491970,"accession":"0001140361-23-057879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-23-057879","line_url":"/filing/0001140361-23-057879#line-1","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":37.31,"price_display":"37.31","price_state":"stated","total_value":186550.0,"total_display":"186,550.00","total_whole":"186,550","shares_owned_after":26802.0,"shares_owned_after_display":"26,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-15","scope":"insider"},{"id":5442964,"accession":"0001593968-21-001334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-21-001334","line_url":"/filing/0001593968-21-001334#line-1","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.5222,"price_display":"50.52","price_state":"stated","total_value":252611.0,"total_display":"252,611.00","total_whole":"252,611","shares_owned_after":26602.0,"shares_owned_after_display":"26,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-17","scope":"insider"},{"id":5382019,"accession":"0001593968-21-001317","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001593968-21-001317","line_url":"/filing/0001593968-21-001317#line-5","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":48.8789,"price_display":"48.88","price_state":"stated","total_value":107533.58,"total_display":"107,533.58","total_whole":"107,534","shares_owned_after":31602.0,"shares_owned_after_display":"31,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":5382016,"accession":"0001593968-21-001317","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-001317","line_url":"/filing/0001593968-21-001317#line-4","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13448.0,"shares_display":"13,448","price_per_share":50.1132,"price_display":"50.11","price_state":"stated","total_value":673922.3136,"total_display":"673,922.31","total_whole":"673,922","shares_owned_after":33802.0,"shares_owned_after_display":"33,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":8687597,"accession":"0001593968-19-000089","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-19-000089","line_url":"/filing/0001593968-19-000089","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":16.8308,"price_display":"16.83","price_state":"stated","total_value":378693.0,"total_display":"378,693.00","total_whole":"378,693","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider","n_lines":2},{"id":6551546,"accession":"0001593968-18-000934","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001593968-18-000934","line_url":"/filing/0001593968-18-000934","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.06,"price_display":"12.06","price_state":"stated","total_value":361800.0,"total_display":"361,800.00","total_whole":"361,800","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-18","filed_date":"2018-06-20","scope":"insider","n_lines":3},{"id":7030636,"accession":"0001181431-14-002925","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-002925","line_url":"/filing/0001181431-14-002925#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22900.0,"shares_display":"22,900","price_per_share":5.0986,"price_display":"5.10","price_state":"stated","total_value":116757.94,"total_display":"116,757.94","total_whole":"116,758","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-17","scope":"insider"},{"id":4289755,"accession":"0001181431-13-062233","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-062233","line_url":"/filing/0001181431-13-062233#line-4","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18100.0,"shares_display":"18,100","price_per_share":4.0026,"price_display":"4.00","price_state":"stated","total_value":72447.06,"total_display":"72,447.06","total_whole":"72,447","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-09","filed_date":"2013-12-10","scope":"insider"},{"id":4289744,"accession":"0001181431-13-062233","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-062233","line_url":"/filing/0001181431-13-062233#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46000.0,"shares_display":"46,000","price_per_share":4.0043,"price_display":"4.00","price_state":"stated","total_value":184197.8,"total_display":"184,197.80","total_whole":"184,198","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-06","filed_date":"2013-12-10","scope":"insider"},{"id":4551029,"accession":"0001181431-13-052324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-052324","line_url":"/filing/0001181431-13-052324#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":4.186,"price_display":"4.19","price_state":"stated","total_value":146510.0,"total_display":"146,510.00","total_whole":"146,510","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-03","scope":"insider"},{"id":4592000,"accession":"0001181431-13-047803","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-047803","line_url":"/filing/0001181431-13-047803#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":4.4108,"price_display":"4.41","price_state":"stated","total_value":154378.0,"total_display":"154,378.00","total_whole":"154,378","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-03","filed_date":"2013-09-05","scope":"insider"},{"id":5529123,"accession":"0001181431-13-042806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-042806","line_url":"/filing/0001181431-13-042806#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":4.4169,"price_display":"4.42","price_state":"stated","total_value":154591.5,"total_display":"154,591.50","total_whole":"154,592","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-01","filed_date":"2013-08-05","scope":"insider"},{"id":4914757,"accession":"0001181431-13-038732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-038732","line_url":"/filing/0001181431-13-038732#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":4.1421,"price_display":"4.14","price_state":"stated","total_value":144973.5,"total_display":"144,973.50","total_whole":"144,974","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-03","scope":"insider"},{"id":5447313,"accession":"0001181431-13-032914","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-032914","line_url":"/filing/0001181431-13-032914#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":4.0091,"price_display":"4.01","price_state":"stated","total_value":501137.5,"total_display":"501,137.50","total_whole":"501,138","shares_owned_after":708734.0,"shares_owned_after_display":"708,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-03","filed_date":"2013-06-05","scope":"insider"},{"id":5415933,"accession":"0001181431-13-026289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-026289","line_url":"/filing/0001181431-13-026289#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.035,"price_display":"4.04","price_state":"stated","total_value":40350.0,"total_display":"40,350.00","total_whole":"40,350","shares_owned_after":523547.0,"shares_owned_after_display":"523,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-06","filed_date":"2013-05-08","scope":"insider"},{"id":4589148,"accession":"0001181431-13-002833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-002833","line_url":"/filing/0001181431-13-002833#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.012,"price_display":"4.01","price_state":"stated","total_value":100300.0,"total_display":"100,300.00","total_whole":"100,300","shares_owned_after":537393.0,"shares_owned_after_display":"537,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-08","filed_date":"2013-01-10","scope":"insider"},{"id":3551341,"accession":"0001181431-12-062853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-062853","line_url":"/filing/0001181431-12-062853#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.0003,"price_display":"4.00","price_state":"stated","total_value":100007.5,"total_display":"100,007.50","total_whole":"100,008","shares_owned_after":537393.0,"shares_owned_after_display":"537,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-04","filed_date":"2012-12-06","scope":"insider"},{"id":7199494,"accession":"0001140361-10-034822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-10-034822","line_url":"/filing/0001140361-10-034822#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"AIS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":312937.0,"shares_owned_after_display":"312,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-24","filed_date":"2010-08-24","scope":"insider"},{"id":5613667,"accession":"0001016169-09-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001016169-09-000005","line_url":"/filing/0001016169-09-000005","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"AIS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.40255,"price_display":"0.40","price_state":"stated","total_value":8051.0,"total_display":"8,051.00","total_whole":"8,051","shares_owned_after":174091.0,"shares_owned_after_display":"174,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-30","filed_date":"2009-03-31","scope":"insider","n_lines":2},{"id":4122684,"accession":"0001016169-08-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001016169-08-000073","line_url":"/filing/0001016169-08-000073#line-1","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"AIS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001300997","owner_name":"Wotton Paul K","owner_display_name":"Wotton Paul K","owner_url":"/insider/0001300997","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.48,"price_display":"0.48","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":154091.0,"shares_owned_after_display":"154,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-17","filed_date":"2008-11-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000887359","name":"Vericel Corp","url":"/issuer/0000887359","role":"Director","n_filings":8,"first_seen":"2018-06-20","last_seen":"2026-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001016169","name":"ANTARES PHARMA, INC.","url":"/issuer/0001016169","role":"Director, Officer (President and CEO)","n_filings":13,"first_seen":"2008-11-19","last_seen":"2014-01-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001300997","retrieved_at":"2026-08-22T23:30:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}